News

Gladstone in the News January 26, 2023

The Race to Supercharge Cancer-Fighting T Cells

Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.

Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing

Article December 20, 2022

Biomedical Research That “Flows” in New Directions

Improvements in the cell analysis technique known as flow cytometry are helping Gladstone researchers make discoveries in immunology, stem cell biology, cardiology, and neuroscience

Gladstone Experts Flow Cytometry Core Neurological Disease Alexanian Lab Roan Lab

Article December 16, 2022

Tips from Virologists to Face the “Tripledemic” This Holiday Season

Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter

Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab

Gladstone in the News December 10, 2022

New COVID Subvariants Are ‘the Most Immune Evasive Yet.’ Here’s What That Means

San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.

Gladstone Experts COVID-19 Virology Roan Lab

Article December 9, 2022

Top Stories of 2022

Revisit some of Gladstone’s most important stories from the past year

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Genomic Immunology Neurological Disease Virology

Article December 7, 2022

Re-Engineering the Human Immune System

Researchers at the Gladstone-UCSF Institute of Genomic Immunology are learning how to harness the power of the human immune system in new ways

Gladstone Experts Cancer Genomic Immunology Carnevale Lab Doudna Lab Marson Lab Pelka Lab Roybal Lab Tang Lab Ye Lab

Gladstone in the News December 2, 2022

Time to Wear a Mask Again? Here’s What Bay Area Health Experts Say amid Rising COVID Cases

San Francisco Chronicle—Although requirements for mask wearing and social distancing have eased around the country, a third winter of the pandemic is looming. Gladstone Senior Investigator Warner Greene recommends paying attention to local trends in case numbers to decide which COVID-19 precautions to take.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News December 1, 2022

COVID Cases and Hospitalizations Are Surging Again in California. What Will It Mean This Time?

San Francisco Chronicle—In an update to a previous article, Senior Investigator Warner Greene now expects both COVID and flu to spread during the holidays and encourages people in high-risk groups to take extra precautions to avoid infection.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Gladstone in the News November 17, 2022

‟Swarm” of Variants Is Driving up California COVID Cases. Is This the Start of the Next Surge?

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, shares his views on the likelihood of a new COVID surge this winter.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News November 15, 2022

InvisiShield Technologies Announces the Appointment of Warner C. Greene, MD, PhD as President and Chief Scientific Officer

Invisishield Technologies—Gladstone Senior Investigator Warner Greene has been appointed President and Chief Scientific Officer of Invisihield Technologies. Invisishield is focused on developing intranasal preventatives for respiratory viruses, including SARS-CoV-2.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News November 3, 2022

Medical Milestones Are Underway at San Francisco’s Gladstone Institutes

Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.

Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs

Gladstone in the News October 20, 2022

Scientists Explain What We Should Expect as COVID Variants Xbb, Bq.1 Spread in Europe, Asia

ABC7 News—Senior Investigator Nadia Roan, PhD, says that a winter surge of infections from the highly transmissible new variants of SARS-CoV-2 currently emerging in the US is likely, but it remains unclear how bad it will be.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News October 19, 2022

Hereditary Disease Foundation Announces 2022 Prize Winners for Leadership in Huntington’s Disease Research

Global News Wire—Gladstone Investigator Steve Finkbeiner was awarded the 2022 Leslie Gehry Prize for Innovation in Science. The award recognizes his advancements in developing novel technologies, such as robotic microscopy and deep learning pipelines, that can be used to understand and develop treatments for Huntington’s disease.

Gladstone Experts Huntington’s Disease Center for Systems and Therapeutics Taube-Koret Center for Neurodegenerative Disease Research Finkbeiner Lab Robotic Microscopy

Gladstone in the News October 17, 2022

National Academy of Medicine Elects 100 New Members

National Academy of Medicine—Katie Pollard, PhD, senior investigator and director of the Gladstone Institute of Data Science and Biotechnology, has been elected to the National Academy of Medicine, in recognition of her discovery of fast-evolving regions in the human genome associated with psychiatric diseases, and of her open-source software used worldwide by genome scientists.

Gladstone Experts Data Science and Biotechnology Pollard Lab Big Data Genomics Human Genetics Microbiome

Gladstone in the News October 16, 2022

How Long Does Immunity from the New COVID Bivalent Boosters Last ’in the Real World’?

San Francisco Chronicle—The new bivalent COVID-19 booster shots are recommended for individuals age 5 and up who are at least two months past their last vaccine dose. Gladstone Investigator Nadia Roan explains that the bivalent boosters greatly increase the levels of antibodies that can prevent the Omicron variant from infecting cells.

Gladstone Experts COVID-19 Virology Roan Lab